Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 173-178

  Terplan, Mishka ^a   Temkin, Sarah ^a   Tergas, Ana ^a   Lengyel, Ernst ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Epithelial ovarian cancer; Race; Racial disparity; Single institution study; Survival disparity

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL; PLATINUM;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DEMOGRAPHY; DRUG SENSITIVITY; EPITHELIAL OVARIAN CANCER; EUROPEAN AMERICAN; FEMALE; HEALTH CARE ACCESS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR VOLUME;

AFRICAN AMERICANS; COHORT STUDIES; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 55649106336     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.08.013     Document Type: Article

References (25)

1. ACS. Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta, GA
2. HHS. Healthy People 2010. Department of Health and Human Services 2008 [accessed 2008 Jan 15];Available from: URL: http://www.healthypeople.gov/About/goals.htm
3. Reis L.A.G., Melbert D., Krapcho M., Stinchcomb D.G., Howlader N., Horner M.J., et al. SEER cancer statistics review (2008), National Cancer Institute, Bethesda, MD 1975-2005
4. Surveillance Research Program CSB. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS 7 A.D. April 2 [accessed 2008 Jan 15];Available from: URL: www.seer.cancer.gov
5. Harper S, Lynch J. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. NCI Cancer Surveillance Monograph Series, Number 6. 2005. Bethesda, MD: National Cancer Institute. Ref Type: Serial (Book,Monograph)
6. McGuire V., Herrinton L., and Whittemore A.S. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology 13 2 (2002) 31-34
7. Barnholtz-Sloan J.S., Tainsky M.A., Abrams J., Severson R.K., Qureshi F., Jacques S.M., et al. Ethnic differences in survival among women with ovarian carcinoma. Cancer 94 6 (2002) 886-893
8. Chan J.K., Zhang M., Hu J.M., Shin J.Y., Osann K., and Kapp D.S. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J. Surg. Oncol. 97 2 (2008) 03-7
9. Parham G.P., and Hicks M.L. Racial disparities affecting the reproductive health of African-American women. Med. Clin. North Am. 89 5 (2005) 35-43, 941
10. Barnholtz-Sloan J.S., Schwartz A.G., Qureshi F., Jacques S., Malone J., and Munkarah A.R. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am. J. Obstet. Gynecol. 189 4 (2003) 20-27
11. Du X., Sun C., Milam M., Bodurka D., and Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. Int. J. Gynecol. Cancer (2007)
12. Harlan L.C., Clegg L.X., and Trimble E.L. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J. Clin. Oncol. 21 18 (2003) 488-494
13. Parham G., Phillips J.L., Hicks M.L., Andrews N., Jones W.B., Shingleton H.M., et al. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 80 4 (1997) 16-26
14. Cress R.D., O'Malley C.D., Leiserowitz G.S., and Campleman S.L. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J. Clin. Oncol. 21 8 (2003) 530-535
15. Sawada K., Radjabi A.R., Shinomiya N., Kistner E., Kenny H.A., Salgia R., et al. C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res. 67 4 (2007) 670-680
16. Sawada K., Mitra A.K., Radjabi A.R., Bhaskar V., Kistner E.O., Tretiakova M., et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res. 68 7 (2008 Apr 1) 2329-2339
17. O'Malley C.D., Cress R.D., Campleman S.L., and Leiserowitz G.S. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol. Oncol. 91 3 (2003) 08-15
18. Smith J.P., and Day T.G. Review of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute. Am. J. Obstet. Gynecol. 135 7 (1979) 84-93
19. Fisher R.A. On the interpretation of chi-square from contingency tables and the calculation of p. J.R. Stat. Soc. 85 1 (1922) 7-94
20. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J. Natl. Cancer Inst. 94 5 (2002) 34-57
21. Earle C.C., Schrag D., Neville B.A., Yabroff K.R., Topor M., Fahey A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J. Natl. Cancer Inst. 98 3 (2006) 72-80
22. Schrag D., Earle C., Xu F., Panageas K.S., Yabroff K.R., Bristow R.E., et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J. Natl. Cancer Inst. 98 3 (2006) 63-71
23. Goff B.A., Matthews B.J., Larson E.H., Andrilla C.H., Wynn M., Lishner D.M., et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 109 10 (2007) 031-42
24. Agency for Health Care Research and Quality. 2007 National Health Care Disparities Report. Rockville, MD: U.S. Department of Health and Human Services; 2008 Feb 1. Report No.: 08-0041.
25. Morgan M.A., Behbakht K., Benjamin I., Berlin M., King S.A., and Rubin S.C. Racial differences in survival from gynecologic cancer. Obstetrics and Gynecology 88 6 (1996) 14-18